Overview
Chronic kidney disease with a worldwide prevalence of 10% in the general population is emerging as a major public health priority.
This book provides a comprehensive update analysis of our current understanding of the so-called cardiorenal syndrome, caused by the relationship between renal insufficiency and cardiovascular disease.
It includes a description of epidemiology, of pathophysiologic mechanisms, and therapeutic approaches.
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (28 chapters)
-
Front Matter
-
Chronic Kidney Disease and Cardiovascular Disease Interrelationships
-
Front Matter
-
-
Crosstalk between the Cardiovascular System and the Kidney
-
Front Matter
-
-
Chronic Kidney Disease as a Risk for Cardiovascular Disease
-
Front Matter
-
-
Spectrum of Cardiovascular Disease in Chronic Kidney Disease
-
Front Matter
-
Keywords
About this book
Chronic kidney disease with a worldwide prevalence of 10% in the general population is emerging as a major public health priority. Renal dysfunction is associated with a high risk for cardiovascular complications. The relationship between renal insufficiency and cardiovascular disease, termed the cardiorenal syndrome exists whether impairment of renal function is a consequence of primary renal parenchymal disease or primary heart disease.
Several pathophysiologic mechanisms have been postulated to explain the relationship between renal dysfunction and cardiovascular disease. Recent studies indicate an integrated response of the vascular smooth muscles and glomerular mesangial cells to traditional and uremia related cardiovascular risk factors. Traditional risk factors can incite renal impairment and cardiac damage. As renal function deteriorates, uremia-related risk factors play an increasing role both in reduction in glomerular filtration rate and cardiovascular damage. Several uremia related factors such as uncontrolled hypertension, disturbed glucose insulin metabolism, microalbuminuria, phosphate retention, secondary hyperparathyroidism, myocardial and vascular calcification, hypertensive-uremic cardiomyopathy, inflammation, oxidant injury, and neurohormonal dysregulation have been implicated in the pathogenesis of the cardiorenal syndrome. Recent data suggest that management of the cardiorenal syndrome requires aggressive control of traditional risk factors as well novel approaches to prevent or reverse uremia –related processes.
This book provides a comprehensive update analysis of our current understanding of the cardiorenal syndrome including epidemiology, pathophysiologic mechanisms, and therapeutic approaches.
Reviews
From the reviews:
“The first book to bring together information on this important and recently named entity, cardiorenal syndrome. … Nephrologists, cardiologists, and trainees in both specialties can benefit from the information presented in this book … . The book presents a novel concept regarding the structural and functional similarities between vascular smooth muscle cells and glomerular mesangial cells. … This is an important contribution since it is the first one to comprehensively address this frontier between nephrology and cardiology.” (Mony Fraer, Doody’s Review Service, April, 2011)Editors and Affiliations
Bibliographic Information
Book Title: Cardiorenal Syndrome
Book Subtitle: Mechanisms, Risk and Treatment
Editors: Adel E. Berbari, Giuseppe Mancia
DOI: https://doi.org/10.1007/978-88-470-1463-3
Publisher: Springer Milano
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer-Verlag Milan 2010
Hardcover ISBN: 978-88-470-1462-6Published: 06 July 2010
Softcover ISBN: 978-88-470-5609-1Published: 14 November 2014
eBook ISBN: 978-88-470-1463-3Published: 04 October 2010
Edition Number: 1
Number of Pages: XV, 396
Topics: Cardiology, Nephrology